Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2007
07/24/2007US7247715 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
07/24/2007US7247714 DNA sequences found in the regulatory region of cytoprotective genes that are cytoprotective response elements
07/24/2007US7247712 Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof
07/24/2007US7247708 Modified vitamin K-dependent polypeptides
07/24/2007US7247706 Culture medium for propagating transgenic cells capable of inducing inward conducting cation channels for use in identifictaion of modulators which prevent, heart, nervous system and muscular disorders
07/24/2007US7247705 Proteins having glucose transporter activity
07/24/2007US7247704 Multifunctional protease inhibitors and their use in treatment of disease
07/24/2007US7247703 Anticancer agents; protein complex
07/24/2007US7247700 BID polypeptides and methods of inducing apoptosis
07/24/2007US7247619 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering
07/24/2007US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents
07/24/2007US7247613 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control
07/24/2007US7247612 novel cell surface molecules of mammals
07/24/2007US7247611 Controlling cell migration; angiogenesis inhibitors; ovulation; antiinflammatory agents; antitumor agents; anticancer agents
07/24/2007US7247609 Growth factor modified protein matrices for tissue engineering
07/24/2007US7247608 FGF homolog polypeptides
07/24/2007US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization
07/24/2007US7247473 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
07/24/2007US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
07/24/2007US7247461 Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
07/24/2007US7247454 Methods for recombinant peptide production
07/24/2007US7247452 Isolated polynucleotide; increased biological activity, decreased cytotoxicity as compared to a mature, recombinant, full length KGF expressed in an insect cell expression system
07/24/2007US7247451 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation
07/24/2007US7247450 Secretion, transcription and sporulation genes in Bacillus clausii
07/24/2007US7247449 Fluorescent protein
07/24/2007US7247447 Methods to obtain and use such proteins, antibodies, and inhibitory compounds; treating flea infestations in animals; biological pest control
07/24/2007US7247446 PRO34128 nucleic acids
07/24/2007US7247440 for anorexia nervosa/obesity preventive/therapeutic drugs; kits
07/24/2007US7247437 Contacting a test cell with a candidate agent;measuring replication of the nucleic acid in the test cell and in a control cell not contacted with the candidate agent; comparing replication of the nucleic acid in the test cell with replication of nucleic acid in the control cell
07/24/2007US7247436 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
07/24/2007US7247433 Low cost; simple; reduced lesion mass
07/24/2007US7247432 Comprises nucleotide sequences coding chaperone protein which protects enzymes and cellular systems in extreme heat; polymerase chain reaction; preventing enzymatic aggregation and intracellular precipitation during heat stress
07/24/2007US7247431 Human source leading sequence, gene vector and gene expression strategy
07/24/2007US7247430 Compositions and methods for detecting multidrug resistant strains of M. tuberculosis having mutations in genes of the mutT family
07/24/2007US7247424 Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1
07/24/2007US7247308 Vaccine; polynucleotide; generating antibodies
07/24/2007US7247306 Bacteria strain and bacteriocin produced therefrom
07/24/2007US7247305 Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
07/24/2007US7247299 Heat resistance; controlling Clostridium, Campylobacter, Streptococcus; gastrointestinal disorders; bactericides
07/24/2007CA2162134C Hepatitis-c virus type 4,5 and 6
07/24/2007CA2151236C Stably transfected cell lines expressing gaba-a receptors
07/24/2007CA2121798C Novel cytokine
07/24/2007CA1341536C Transforming growth factor peptides
07/24/2007CA1341535C Transforming growth factor peptides
07/23/2007CA2637947A1 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
07/19/2007WO2007082269A2 Epsp synthase enzyme domains conferring glyphosate resistance
07/19/2007WO2007082264A2 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
07/19/2007WO2007081943A2 Methods and compositions for promoting attachment of cells of endothelial cell lineage to medical devices
07/19/2007WO2007081942A2 Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
07/19/2007WO2007081938A2 Mannheimia haemolytica chimeric outer membrane protein plpe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
07/19/2007WO2007081696A2 Treating androgen decline in aging male (adam)-associated conditions with sarms
07/19/2007WO2007081447A2 Norovirus and sapovirus antigens
07/19/2007WO2007081419A2 Compositions and methods related to anti-fgf agents
07/19/2007WO2007081209A1 Uv-absorbing polymers consisting of gelatin and aminobutadiene
07/19/2007WO2007080977A1 Preventive or therapeutic agent and method for immune disease
07/19/2007WO2007080874A1 Mutant gene fragment of glycopeptide-pooly-sensitive staphylococcus and use thereof
07/19/2007WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same
07/19/2007WO2007080664A1 Marker of primary malignant central nervous system lymphoma and use thereof
07/19/2007WO2007080621A1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
07/19/2007WO2007080597A2 Polynucleotide and polypeptide sequences and methods for diagnosis
07/19/2007WO2007080400A2 Ace n-domain crystal
07/19/2007WO2007080143A1 Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants
07/19/2007WO2007079886A1 Octanoate-reduced human albumin
07/19/2007WO2007079783A1 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof
07/19/2007WO2007079684A1 A mycobacterium tuberculosis fusion protein and uses thereof
07/19/2007WO2007079605A2 Template-fixed peptidomimetics with antimicrobial activity
07/19/2007WO2007079597A1 Template - fixed peptidomimetics with antimicrobial activity
07/19/2007WO2007079592A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration
07/19/2007WO2007079581A1 Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carobxylase
07/19/2007WO2007054600A3 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination
07/19/2007WO2007048086A9 Canine influenza virus and related compositions and methods of use
07/19/2007WO2007046787A3 Methods of reducing repeat-induced silencing of transgene expression and improved fluorescent biosensors
07/19/2007WO2007030637A8 Hiv gp120 crystal structure and its use to identify immunogens
07/19/2007WO2007027777B1 Nucleotide sequences encoding insecticidal proteins
07/19/2007WO2007015174A3 Exosome-specific ligands, their preparartion and uses
07/19/2007WO2006124667A3 Compositions and methods for modulating immune responses
07/19/2007WO2006066024A8 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
07/19/2007WO2006065867A3 Polymer-linked pseudomonas exotoxin immunotoxin
07/19/2007WO2006065821A8 Improved dna immunization with recombinase/transposase
07/19/2007WO2006050159A3 Methods of predicting responsiveness to treatment
07/19/2007WO2006034191A3 Tem17 binds to cortactin
07/19/2007WO2005121377A3 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase
07/19/2007WO2005072057A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
07/19/2007WO2005012492A3 Human skin equivalents expressing exogenous polypeptides
07/19/2007WO2004100886A3 POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
07/19/2007WO2003054144A8 Human ras interacting protein
07/19/2007WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses
07/19/2007WO2001087917A8 Novel nucleic acids and polypeptides
07/19/2007US20070169228 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof
07/19/2007US20070169221 Novel Bt toxin receptors from lepidopteran insects and methods of use
07/19/2007US20070169211 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
07/19/2007US20070169210 Modulators of gamete adhesion include polypeptides comprising at least one discoidin/C domain and optionally EGF domain; medical diagnosis; contraception; fertility
07/19/2007US20070169207 Transgenic nonhuman animal having germ or somatic cell containing nucleic acid encoding human amyloid precursor protein including nucleotides encoding codon 670 and 671; diagnosing and/or predicting predisposition; drug screening
07/19/2007US20070167611 Peptides and Peptidomimetics with Structural Similarity to Human p53 that Activate p53 Function
07/19/2007US20070167610 Recombinant soluble adenovirus receptor
07/19/2007US20070167609 Nanoscale array biomolecular bond enhancer device
07/19/2007US20070167608 Sugar chain structure profiling techniques
07/19/2007US20070167607 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
07/19/2007US20070167405 Galectins -1 and -4 in tumor development
07/19/2007US20070167374 Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)